Drug Shortage Report for EMLA CREAM

Last updated on 2024-07-11 History
Report ID 227423
Drug Identification Number 00886858
Brand name EMLA CREAM
Common or Proper name lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) LIDOCAINE PRILOCAINE
Strength(s) 2.5% 2.5%
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 Tube
ATC code D04AB
ATC description ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2024-07-15
Actual start date
Estimated end date 2024-07-31
Actual end date 2024-07-11
Shortage status Avoided shortage
Updated date 2024-07-11
Company comments CAD2EM012B1 EMLA 50MG/G CRM 5G TUB CA ASP
Health Canada comments
Tier 3 Status No
Contact Address 2030 BRISTOL CIRCLE, SUITE 201
OAKVILLE, ONTARIO
CANADA L6H 0H2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-07-11 French Compare
v5 2024-07-11 English Compare
v4 2024-07-04 French Compare
v3 2024-07-04 English Compare
v2 2024-05-09 French Compare
v1 2024-05-09 English Compare

Showing 1 to 6 of 6